Podcasts about health economics research

Editor in Chief Sue Yom hosts a discussion of An Economic Analysis of SC.24: A Randomized Study of SBRT Compared with Conventional Palliative RT for Spinal Metastases. Guests are first and second author Dr. Marc Kerba, clinical associate professor in the Department of Oncology at the University of Calgary and radiation oncologist at the Tom Baker Cancer Centre, and Dr. Richard De Abreu Lourenco, Professor with the Centre for Health Economics Research and Evaluation at the University of Technology Sydney.

Over the past 18 months, COVID has demonstrated the need for a well funded health system. The cost of dealing with a pandemic has been most clearly borne by our hospitals. So how does the Australian healthcare system stack up comparatively?Guests:Kees Van Gool, Deputy Director and Professor at the Centre for Health Economics Research and Evaluation at UTS and researcher on the ICCONIC project

Deck the halls with forward estimates!Christmas for the finance world has finally arrived, with the Federal Budget 2020 putting pen to paper on a fiscal year for the ages.And with a deficit to the piercing tune of $213 billion dollars, this year’s tea leaves do not paint a pretty picture.Can we hitch our recovery wagon to tax cuts?Will big-spending in business add up alongside a continuation of social distancing?As they say in economics, ‘You can never judge a budget until it’s at least a week old.’Joining me to find out whether this financial Christmas we'll be getting a new bike, or a pair of socks is Nicole Sutton from the UTS Business School’s accounting discipline, Richard De Abreu Lourenco with the Centre for Health Economics Research and Evaluation at the University of Technology Sydney and UTS Business School Industry Professor Warren Hogan.

We’re all anxiously awaiting news in 2020 about a successful vaccine for COVID19, with the Australian Government securing a ‘letter of intent’ with Oxford University and pharmaceutical giant AstraZeneca.But, as we do at Think: Business Futures, it is important to take a closer look at the petri dish, and find out whether the vaccine could bust the virus, or break the bank?Joining us is Dr. Richard De Abreu Lourenco, Associate Professor at the Centre for Health Economics Research and Evaluation at the University of Technology Sydney.And Jennifer Herz, managing director of Biointellect, an Australian strategic planning and market research firm for the biopharmaceutical and medical device sector.

It seems that it often takes a national crisis for cracks in a system to become visible. And under the harsh light of COVID19, the aged care sector has revealed systemic issues in it’s ability to provide adequate care, workers and now, protection against an invisible enemy.Joining host Max Tillman is Professor Michael Woods, Professor of Health Economics at the Center for Health Economics Research and Evaluation (CHERE) at the University of Technology Sydney. He is on the Board of the Australian Digital Health Agency and is a member of the Aged Care Financing Authority.Joining Professor Woods is Ian Henschke, chief advocate for National Seniors Australia.

How capable are Australia's hospitals and healthcare systems of handling COVID19?This week on the program, host Max Tillman is joined by Stephen Duckett, The Health Program Director at The Grattan Institute, Prabhu Sivabalan, Associate Dean of Engagement at the University of Technology Sydney, and Rosalie Viney, Director of the Centre for Health Economics Research and Evaluation at the University of Technology Sydney to talk about the risks our hospitals face when dealing with a pandemic.

On this episode, we’re looking at the costs (hidden and otherwise) of cancer treatment in Australia. David is joined in the studio by Professor Kees Van Gool from the Centre for Health Economics Research and Evaluation (CHERE) and Philip Haywood.Further Reading:You can find more information on the Centre for Health Economics Research and Evaluation (CHERE) on their website.The Sydney Morning Herald explains where out-of-pocket costs for cancer treatment comes from in this article from April 2019.For more information on the 45 And Up Study, visit the Sax Institute website.The full list of NHMRC grant recipients can be found here.Music: Ecobel, Edward Joe Myers, Lotus, Brendon MoellerSFX: Soundmary and freetousounds (Freesound.org) and Monty Python- Kettledrum Films 1971

Welcome to the second part of our interview with Dr. Hugh Waters, Director of Health Economics Research at the Milken Institute.  A few weeks ago, Dr. Waters presented us with the astounding economic costs of the rise of obesity in the United States, both from health expenditures and lost work and wages.  1.7 trillion (with a T) dollars in one year. These costs are not born only by the obese individual but are distributed across society in ways that affect us all.  So, we all need to think about ways to reverse this trend and today Dr. Waters will discuss some ideas about how.      Key Takeaways:   Increasing taxes on sugary and processed foods, like with cigarettes, does decrease the consumption of these unhealthy foods. Subsidizing healthy foods also increases the consumption of healthy foods.  As a society, we need to get involved at all levels, federal, state, local governments, employers, communities, families – everyone plays a role in decreasing the obesity and overweight levels.  The pocketbook is the most effective way to get people’s attention.     "The key is not to make people feel badly about their bodies, but to let them know that they have other options and there are healthy alternatives and ways to lead full, healthy lives." —  Dr. Hugh Waters      Connect with Dr. Hugh Waters:    Milken Institute: Hugh Waters     Milken Institute Report:  Economic impact of excess weight now exceeds $1.7 trillion, new Milken Institute report reveals.       Connect with Therese:   Website:   www.criticallyspeaking.net  Twitter: @CritiSpeak   Email: theresemarkow@criticallyspeaking.net         Audio production by Turnkey Podcast Productions. You're the expert. Your podcast will prove it.    

A report released in January by Deloitte Access Economics found the cost of cancer for 15-25 year olds in Australia nears $1.4 million over their lifetime. This episode we look at what these costs are and what’s being done to bring them down.Featuring:Gemma Crawley.Alison Pearce - Chancellor’s Postdoctoral Research Fellow in the Centre for Health Economics Research and Evaluation at the University of Technology Sydney.Sondra Davoren - Senior Legal Policy Advisor in the McCabe Centre for Law and Cancer, Cancer Council Victoria.

Professor Kees Van Gool, Associate Professor at Centre for Health Economics Research and Evaluation (CHERE)- University of Technology SydneyProduced by: Jess Klajman, Annastasia Diaczok and Tim Wang 

Rosalie Viney, Professor of Health Economics and Director of the Centre for Health Economics Research and Evaluation at the University of Technology SydneyProduced by: Jess Klajman, Annastasia Diaczok and Tim Wang 

Professor Jane Hall, from the Centre for Health Economics Research and Evaluation at the University of Technology Sydney on her proposal for a new option for Australians to pay their healthcare costs.